Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study

BACKGROUND: Several studies have reported suboptimal efficacy of direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV) subtypes endemic to sub-Saharan Africa (SSA) and Southeastern Asia (SEA). The extent of this issue in individuals with human immunodeficiency virus (HIV)/HCV from SSA or...

Descripción completa

Detalles Bibliográficos
Autores principales: Isfordink, Cas, Boyd, Anders, Mocroft, Amanda, Kusejko, Katharina, Smit, Colette, de Wit, Stephane, Mahungu, Tabitha, Falconer, Karolin, Wandeler, Gilles, Cavassini, Matthias, Stöckle, Marcel, Schinkel, Janke, Rauch, Andri, Peters, Lars, van der Valk, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605702/
https://www.ncbi.nlm.nih.gov/pubmed/36320198
http://dx.doi.org/10.1093/ofid/ofac508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605702/
https://www.ncbi.nlm.nih.gov/pubmed/36320198
http://dx.doi.org/10.1093/ofid/ofac508

Ejemplares similares